Evaluation of Effects of Artemether + Lumefantrine (Artemisinin-based Combination Therapy) on Women’s Reproductive Cycle using Creighton Model FertilityCare System and NaProTECHNOLOGY
DOI:
https://doi.org/10.60787/njgp.v15i2.121Keywords:
NaProTECHNOLOGY, infertility, Creighton Model FertilityCare System, Artemether + lumefantrineAbstract
Background: Malaria is prevalent in Nigeria, and artemether + lumefantrine (artemisinin-based combination therapy [ACT]) is drug of choice in treatment of uncomplicated cases. ACT is contraindicated in early pregnancy. They release-free radicals that can compromise
female fertility. Infertility and its associated complications such as miscarriages, abnormal gestation, and unstable marriages seem to be on the increase. This study aims at evaluating the effect of ACT on female fertility. The significance of this research is to draw the attention of fertility care givers to this possible cause of infertility and fertility challenges.
Subjects and Methods: Creighton Model FertilityCare System and NaProTECHNOLOGY are simply technologies that can be used to assess female fertility. They are used in this study to assess the effect of ACT administered at different stages of menstrual cycles of three selected fertile adult females. The results are interpreted on the background of standard Creighton model chart.
Results: This study has shown that ACT has a significant fertility deteriorating effect on the women. It caused ovulation defect and diagnosed as partial rupture syndrome in the very cycle of use and in the first cycle after use. It also significantly reduced cervical mucus production and significantly reduced luteal phase progesterone production with an associated significant increase of luteal phase estrogen production.
Conclusion: ACT use as antimalarial may be a possible cause of infertility and fertility challenges in women.
Downloads
References
Ezenduka CC, Ogbonna BO, Ekwunife OI, Okonta MJ, Esimone CO. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, Southeast Nigeria: Implications for malaria treatment policy. Malar J 2014;13:243.
Nigeria Malaria Fact Sheet. United States Embassy in Nigeria. Economic Section, United States Embassy in Nigeria Plot 1075. Diplomatic Drive Central Area Abuja, FCT, Nigeria; December, 2011.
Available from: http://www.photos.state.gov/libraries/nigeria/231771/Public/December-MalariaFactSheet2.pdf
Warhurst DC, Adagu IS, Beck HP, Duraisingh MT, Kirby GC, von Seidlein L, et al. Mode of action of artemether lumefantrine (COARTEM): The sole, fixed, oral ADCC and its role in combatting
multidrug resistance. Southeast Asian J Trop Med Public Health 2001;32 Suppl 1:4‑8.
Dennery PA. Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal 2004;6:147‑53.
Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Biol 2004;3:177‑99.
Agarwal A, Allamaneni SS. Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online 2004;9:338‑47.
Bedaiwy MA1, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 2002;17:426‑31.
Olumide SA, Raji Y. Long-term administration of artesunate induces reproductive toxicity in male rats. J Reprod Infertil 2011;12:249-60.
Abolaji AO, Eteng MU, Ebong PE, Dar A, Farombi EO, Choudhary MI. Artemisia annua as a possible contraceptive agent: A clue from mammalian rat model. Nat Prod Res 2014;28:2342‑6.
Obianime AW, Aprioku JS. Comparative study of artesunate, ACTs and their combinants on the hormonal parameters of the male guinea pig. Niger J Physiol Sci 2009;24:101-6.
IzunyaAM, NwaoparaAO, AigbiremolenAE, Odike MA, Oaikhena GA, Bankole JK. Histological studies of the toxicity of artesunate on the testes in Wistar rats. Biol Med 2010;2:49-56.
Adeeko AO, Dada OA. Chloroquine reduces fertilizing capacity of epididyma sperm in rats. Afr J Med Med Sci 1998;27:63‑4.
Hilgers TW, Abraham GE, Cavanagh D. Natural family planning. I. The peak symptom and estimated time of ovulation. Obstet Gynecol 1978;52:575-82.
Moghissi KS, Syner FN, Evans TN. Acomposite picture of the menstrual cycle. Am J Obstet Gynecol 1972;114:405-18.
Insler V, Glezerman M, Zeidel L, Bernstein D, Misgav N. Sperm storage in the human cervix: A quantitative study. Fertil Steril 1980;33:288‑93.
Hilgers TW. The Medical and Surgical Practice of NaProTechnology. Omaha, Nebraska, USA: Pope Paul VI Institute Press; 2004.
Hilgers TW. Text Book of Medical and Surgical Practice of NaProTechnology. 1st ed., Ch. 24. Nebraska 68106 USA: Pope Paul VI institute Press; 2004.
Ma WG, Song H, Das SK, Paria BC, Dey SK. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci U S A 2003;100:2963‑8.
Hilgers TW. The objective assessment of the vulvar mucus cycle. Int Rev Fam Plan 1988;12:250-8.
Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141‑4.
Hilgers TW. The Medical and Surgical Practice of NaProTechnology. 1st ed. Omaha, Nebraska, USA: Pope Paul VI Institute Press; 2004. p. 784.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nigerian Journal of General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
